Literature DB >> 17963045

A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups.

N R Bindraban1, I G M van Valkengoed, G Mairuhu, R W Koster, F Holleman, J B L Hoekstra, R P Koopmans, K Stronks.   

Abstract

We used a population based study in the Netherlands of 330 Hindustani Surinamese, 586 African Surinamese, and 486 ethnic Dutch (Dutch) to describe the prevalence of the metabolic syndrome (MS) and the association with differences in cardiovascular disease in and between ethnic groups. Fasting blood samples, blood pressure, and anthropometric measurements were obtained. MS was defined according to the criteria of the International Diabetes Federation (IDF) and the criteria of the National Cholesterol Education Program (NCEP). Cardiovascular disease was assessed by the Rose questionnaire and included questions on previous diagnoses of angina pectoris/myocardial infarction, cerebrovascular accident, intermittent claudication. The prevalence of MS (IDF and NCEP) was highest in Hindustani Surinamese men, followed by Dutch and African Surinamese men: 51.0%, 19.4%, and 31.2% (IDF), respectively. Among women, both the Hindustani and African Surinamese participants had a higher prevalence of MS (IDF and NCEP) than the Dutch. The association between the components, MS and cardiovascular disease differed between ethnic groups, in particular among men; OR for MS (NCEP) = 1.0 (0.4-2.7) among Hindustani Surinamese, OR = 4.9 (1.3-18.3) among African Surinamese, and OR = 2.8 (1.1-7.1) among Dutch. However, the differences in MS could not account for the ethnic differences in cardiovascular disease, regardless of the criteria used. The results suggest that, before the criteria can be used to guide practice, they may need to be changed and refined to take into account the differences between ethnic groups as well as the variations by gender.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963045     DOI: 10.1007/s10654-007-9200-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  [Cardiovascular risk factors for Surinamese in the Netherlands: a literature review].

Authors:  N R Bindraban; K Stronks; N S Klazinga
Journal:  Ned Tijdschr Geneeskd       Date:  2003-08-16

3.  The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.

Authors:  G A ROSE
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

4.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

5.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.

Authors:  David W Dunstan; Paul Z Zimmet; Timothy A Welborn; Maximilian P De Courten; Adrian J Cameron; Richard A Sicree; Terry Dwyer; Stephen Colagiuri; Damien Jolley; Matthew Knuiman; Robert Atkins; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

6.  Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors.

Authors:  P Fornengo; A Bosio; G Epifani; O Pallisco; A Mancuso; C Pascale
Journal:  Diabet Med       Date:  2006-07       Impact factor: 4.359

7.  Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.

Authors:  T Tillin; N Forouhi; D G Johnston; P M McKeigue; N Chaturvedi; I F Godsland
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

8.  Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.

Authors:  Naveed Sattar; Allan Gaw; Olga Scherbakova; Ian Ford; Denis St J O'Reilly; Steven M Haffner; Chris Isles; Peter W Macfarlane; Chris J Packard; Stuart M Cobbe; James Shepherd
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

9.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

Authors:  Gang Hu; Qing Qiao; Jaakko Tuomilehto; Beverley Balkau; Knut Borch-Johnsen; Kalevi Pyorala
Journal:  Arch Intern Med       Date:  2004-05-24

10.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

View more
  11 in total

1.  Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?

Authors:  Ines N Hahntow; Gideon Mairuhu; Irene Gm van Valkengoed; Richard P Koopmans; Martin C Michel
Journal:  BMC Cardiovasc Disord       Date:  2010-06-02       Impact factor: 2.298

2.  The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin.

Authors:  Mariska van Vliet; Inès A von Rosenstiel; Roger K Schindhelm; Desiderius P M Brandjes; Jos H Beijnen; Michaela Diamant
Journal:  Eur J Pediatr       Date:  2008-08-12       Impact factor: 3.183

3.  The association of leisure-time physical activity and active commuting with measures of socioeconomic position in a multiethnic population living in the Netherlands: results from the cross-sectional SUNSET study.

Authors:  Jeroen S L de Munter; Charles Agyemang; Lizzy M Brewster; Karien Stronks; Irene G M van Valkengoed
Journal:  BMC Public Health       Date:  2012-09-21       Impact factor: 3.295

4.  The Generation R Study: design and cohort update 2010.

Authors:  Vincent W V Jaddoe; Cock M van Duijn; Albert J van der Heijden; Johan P Mackenbach; Henriëtte A Moll; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-10-22       Impact factor: 8.082

5.  Type D personality is associated with increased metabolic syndrome prevalence and an unhealthy lifestyle in a cross-sectional Dutch community sample.

Authors:  Paula M C Mommersteeg; Nina Kupper; Johan Denollet
Journal:  BMC Public Health       Date:  2010-11-19       Impact factor: 3.295

6.  Large ethnic variations in recommended physical activity according to activity domains in amsterdam, the netherlands.

Authors:  Jeroen Sl de Munter; Irene Gm van Valkengoed; Charles Agyemang; Anton E Kunst; Karien Stronks
Journal:  Int J Behav Nutr Phys Act       Date:  2010-11-29       Impact factor: 6.457

7.  How can we realise the potentially large public health benefit of screening for type 2 diabetes mellitus in south Asians?

Authors:  K Stronks; I G M van Valkengoed
Journal:  Diabetologia       Date:  2011-07-16       Impact factor: 10.122

8.  How do psychosocial determinants in migrant women in the Netherlands differ from these among their counterparts in their country of origin? A cross-sectional study.

Authors:  Vera Nierkens; Maya V van der Ploeg; Marja Y van Eer; Karien Stronks
Journal:  BMC Public Health       Date:  2011-05-26       Impact factor: 3.295

9.  Total physical activity might not be a good measure in the relationship with HDL cholesterol and triglycerides in a multi-ethnic population: a cross-sectional study.

Authors:  Jeroen S L de Munter; Irene G van Valkengoed; Karien Stronks; Charles Agyemang
Journal:  Lipids Health Dis       Date:  2011-11-30       Impact factor: 3.876

10.  Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes.

Authors:  Sjaam Jainandunsing; Behiye Özcan; Trinet Rietveld; Joram N I van Miert; Aaron J Isaacs; Janneke G Langendonk; Felix W M de Rooij; Eric J G Sijbrands
Journal:  Acta Diabetol       Date:  2014-05-05       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.